Skip to content
PubMed This is a summary of 104 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 104 referenced papers

Top Authors

Sean J. Pittock
Mayo Clinic
Eoin P. Flanagan
Mayo Clinic
Divyanshu Dubey
Mayo Clinic
Andrew McKeon
Mayo Clinic
Sarosh R. Irani
John Radcliffe Hospital
Soon‐Tae Lee
Seoul National University Hospital
Russell C. Dale
The University of Sydney
Sudarshini Ramanathan
The University of Sydney

Top Institutions

Ranked by publications Top 10 institutions

References

References (104)
  1. 1

    Immune therapy in autoimmune encephalitis: a systematic review.

    Nosadini M, Mohammad SS, Ramanathan S, et al.

    Expert review of neurotherapeutics 2015; (15(12)):1391-419 doi:10.1586/14737175.2015.1115720.

    PMID: 26559389
  2. 2

    [Fisher Syndrome and Bickerstaff Brainstem Encephalitis].

    Kuwabara S

    Brain and nerve = Shinkei kenkyu no shinpo 2015; (67(11)):1371-6 doi:10.11477/mf.1416200308.

    PMID: 26560952
  3. 3

    The Diagnosis and Treatment of Autoimmune Encephalitis.

    Lancaster E

    Journal of clinical neurology (Seoul, Korea) 2016; (12(1)):1-13 doi:10.3988/jcn.2016.12.1.1.

    PMID: 26754777
  4. 4

    Autoimmune encephalitis.

    Newman MP, Blum S, Wong RC, et al.

    Internal medicine journal 2016; (46(2)):148-57 doi:10.1111/imj.12974.

    PMID: 26899887
  5. 5

    A clinical approach to diagnosis of autoimmune encephalitis.

    Graus F, Titulaer MJ, Balu R, et al.

    The Lancet. Neurology 2016; (15(4)):391-404.

    PMID: 26906964
  6. 6

    Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease.

    Long L, Xu L, Xiao Z, et al.

    Scientific reports 2016; (6()):23444 doi:10.1038/srep23444.

    PMID: 27001010
  7. 7

    Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.

    Lee WJ, Lee ST, Byun JI, et al.

    Neurology 2016; (86(18)):1683-91 doi:10.1212/WNL.0000000000002635.

    PMID: 27037228
  8. 8

    Rapid Aspiration Screening for Suspected Stroke: Part 1: Development and Validation.

    Daniels SK, Pathak S, Rosenbek JC, et al.

    Archives of physical medicine and rehabilitation 2016; (97(9)):1440-1448 doi:10.1016/j.apmr.2016.03.025.

    PMID: 27117382
  9. 9

    The Brainstem Tau Cytoskeletal Pathology of Alzheimer's Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance.

    Rüb U, Stratmann K, Heinsen H, et al.

    Current Alzheimer research 2016; (13(10)):1178-97 doi:10.2174/1567205013666160606100509.

    PMID: 27264543
  10. 10

    MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

    Jarius S, Kleiter I, Ruprecht K, et al.

    Journal of neuroinflammation 2016; (13(1)):281 doi:10.1186/s12974-016-0719-z.

    PMID: 27802825
  11. 11

    Accuracy of endoscopic and videofluoroscopic evaluations of swallowing for oropharyngeal dysphagia.

    Giraldo-Cadavid LF, Leal-Leaño LR, Leon-Basantes GA, et al.

    The Laryngoscope 2017; (127(9)):2002-2010 doi:10.1002/lary.26419.

    PMID: 27859291
  12. 12

    Management of acute neuromuscular disorders.

    Wijdicks EF

    Handbook of clinical neurology 2017; (140()):229-237 doi:10.1016/B978-0-444-63600-3.00013-1.

    PMID: 28187801
  13. 13

    Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.

    Watad A, Amital H, Shoenfeld Y

    Lupus 2017; (26(10)):1015-1022 doi:10.1177/0961203317696589.

    PMID: 28420062
  14. 14

    Slowly progressing varicella zoster brainstem encephalitis complicating Ramsay Hunt syndrome in an immunocompetent patient: case report and review of the literature.

    Ricigliano VAG, Saraceno L, Cavalli M, et al.

    Journal of neurovirology 2017; (23(6)):922-928 doi:10.1007/s13365-017-0575-3.

    PMID: 28905216
  15. 15

    Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

    Tobin WO, Guo Y, Krecke KN, et al.

    Brain : a journal of neurology 2017; (140(9)):2415-2425 doi:10.1093/brain/awx200.

    PMID: 29050399
  16. 16

    Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

    Dubey D, Pittock SJ, Kelly CR, et al.

    Annals of neurology 2018; (83(1)):166-177 doi:10.1002/ana.25131.

    PMID: 29293273
  17. 17

    Clinical Application of Flexible Endoscopic Evaluation of Swallowing in Stroke.

    Pisegna JM, Murray J

    Seminars in speech and language 2018; (39(1)):3-14 doi:10.1055/s-0037-1608855.

    PMID: 29359301
  18. 18

    Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation.

    Nikolaus M, Knierim E, Meisel C, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2018; (22(3)):558-562 doi:10.1016/j.ejpn.2018.01.002.

    PMID: 29396172
  19. 19

    Acute encephalitis - diagnosis and management.

    Ellul M, Solomon T

    Clinical medicine (London, England) 2018; (18(2)):155-159 doi:10.7861/clinmedicine.18-2-155.

    PMID: 29626021
  20. 20

    An Update on the Treatment of Pediatric Autoimmune Encephalitis.

    Stingl C, Cardinale K, Van Mater H

    Current treatment options in rheumatology 2018; (4(1)):14-28 doi:10.1007/s40674-018-0089-z.

    PMID: 29780690
  21. 21

    Acute Respiratory Failure in Children.

    Friedman ML, Nitu ME

    Pediatric annals 2018; (47(7)):e268-e273 doi:10.3928/19382359-20180625-01.

    PMID: 30001440
  22. 22

    The princess and the p-value: A case report of suspected autoimmune encephalitis and functional neurological disorder in a pediatric patient.

    Wilkinson-Smith A, Greenberg B, Keech A

    Applied neuropsychology. Child 2020; (9(1)):13-20 doi:10.1080/21622965.2018.1501373.

    PMID: 30265565
  23. 23

    Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis.

    Ricken G, Schwaiger C, De Simoni D, et al.

    Frontiers in neurology 2018; (9()):841 doi:10.3389/fneur.2018.00841.

    PMID: 30364136
  24. 24

    Citrobacter freundii sepsis in an immunosuppressed patient with pemphigus vulgaris.

    Ferranti M, Tadiotto Cicogna G, Sattin A, Alaibac M

    BMJ case reports 2018; (11(1)) doi:10.1136/bcr-2018-227091.

    PMID: 30567283
  25. 25

    CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

    Taieb G, Mulero P, Psimaras D, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(9)):1027-1038 doi:10.1136/jnnp-2018-318957.

    PMID: 31072955
  26. 26

    Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis.

    Ayzenberg I, Ellrichmann G, Schroeder C, et al.

    Frontiers in neurology 2019; (10()):829 doi:10.3389/fneur.2019.00829.

    PMID: 31428040
  27. 27

    Brainstem dysfunction in critically ill patients.

    Benghanem S, Mazeraud A, Azabou E, et al.

    Critical care (London, England) 2020; (24(1)):5 doi:10.1186/s13054-019-2718-9.

    PMID: 31907011
  28. 28

    Efficacy and safety of rituximab in autoimmune encephalitis: A meta-analysis.

    Nepal G, Shing YK, Yadav JK, et al.

    Acta neurologica Scandinavica 2020; (142(5)):449-459 doi:10.1111/ane.13291.

    PMID: 32484900
  29. 29

    Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.

    Dubey D, Wilson MR, Clarkson B, et al.

    JAMA neurology 2020; (77(11)):1420-1429 doi:10.1001/jamaneurol.2020.2231.

    PMID: 32744608
  30. 30

    Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.

    Jarius S, Pellkofer H, Siebert N, et al.

    Journal of neuroinflammation 2020; (17(1)):261 doi:10.1186/s12974-020-01824-2.

    PMID: 32883348
  31. 31

    Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis.

    Budhram A, Dubey D, Sechi E, et al.

    Clinical chemistry 2020; (66(12)):1496-1509 doi:10.1093/clinchem/hvaa254.

    PMID: 33221892
  32. 32

    Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience.

    Budhram A, Mirian A, McFadden S, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021; (48(6)):859-863 doi:10.1017/cjn.2021.23.

    PMID: 33557967
  33. 33

    Clinical efficacy of plasma exchange in patients with autoimmune encephalitis.

    Zhang Y, Huang HJ, Chen WB, et al.

    Annals of clinical and translational neurology 2021; (8(4)):763-773 doi:10.1002/acn3.51313.

    PMID: 33609012
  34. 34

    Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.

    Abboud H, Probasco J, Irani SR, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-325302.

    PMID: 33649021
  35. 35

    Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.

    Abboud H, Probasco JC, Irani S, et al.

    Journal of neurology, neurosurgery, and psychiatry 2021; (92(7)):757-768 doi:10.1136/jnnp-2020-325300.

    PMID: 33649022
  36. 36

    Rhombencephalitis due to Listeria monocytogenes infection with GQ1b antibody positivity and multiple intracranial hemorrhage: a case report and literature review.

    Zhao Y, Xu C, Tuo H, et al.

    The Journal of international medical research 2021; (49(4)):300060521998568 doi:10.1177/0300060521998568.

    PMID: 33866842
  37. 37

    Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology.

    Dziewas R, Allescher HD, Aroyo I, et al.

    Neurological research and practice 2021; (3(1)):23 doi:10.1186/s42466-021-00122-3.

    PMID: 33941289
  38. 38

    Autoimmune Neurology: The Need for Comprehensive Care.

    Abbatemarco JR, Rodenbeck SJ, Day GS, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2021; (8(5)) doi:10.1212/NXI.0000000000001033.

    PMID: 34131068
  39. 39

    On clinical findings of Bickerstaff's brainstem encephalitis in childhood.

    Messina G, Sciuto S, Fontana A, et al.

    Journal of integrative neuroscience 2021; (20(2)):509-513 doi:10.31083/j.jin2002054.

    PMID: 34258953
  40. 40

    How Patients with an Uncertain Diagnosis Experience Intolerance of Uncertainty: A Grounded Theory Study.

    Yang Z, Zhao X, Zhu Z, et al.

    Psychology research and behavior management 2021; (14()):1269-1279 doi:10.2147/PRBM.S318263.

    PMID: 34408511
  41. 41

    Validation of the Clinical Assessment Scale for Autoimmune Encephalitis: A Multicenter Study.

    Cai MT, Lai QL, Zheng Y, et al.

    Neurology and therapy 2021; (10(2)):985-1000 doi:10.1007/s40120-021-00278-9.

    PMID: 34476753
  42. 42

    The brainstem in multiple sclerosis: MR identification of tracts and nuclei damage.

    Nguyen TH, Vaussy A, Le Gaudu V, et al.

    Insights into imaging 2021; (12(1)):151 doi:10.1186/s13244-021-01101-7.

    PMID: 34674050
  43. 43

    Neurological and cognitive outcomes after antibody-negative autoimmune encephalitis in children.

    Gadian J, Eyre M, Konstantoulaki E, et al.

    Developmental medicine and child neurology 2022; (64(5)):649-653 doi:10.1111/dmcn.15101.

    PMID: 34724211
  44. 44

    Brain biopsy in patients with CLIPPERS syndrome: why and when.

    Galazky I, Büntjen L, Voges J, et al.

    Therapeutic advances in neurological disorders 2022; (15()):17562864211062821 doi:10.1177/17562864211062821.

    PMID: 35126669
  45. 45

    The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.

    Lee ST, Lee HS, Lee WJ, et al.

    Annals of clinical and translational neurology 2022; (9(5)):610-621 doi:10.1002/acn3.51540.

    PMID: 35315247
  46. 46

    Multidisciplinary Care of Patients with Inherited Metabolic Diseases and Epilepsy: Current Perspectives.

    Tumienė B, Del Toro Riera M, Grikiniene J, et al.

    Journal of multidisciplinary healthcare 2022; (15()):553-566 doi:10.2147/JMDH.S251863.

    PMID: 35387391
  47. 47

    Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.

    Lee WJ, Lee HS, Kim DY, et al.

    Brain : a journal of neurology 2022; (145(10)):3509-3521 doi:10.1093/brain/awac166.

    PMID: 35512357
  48. 48

    Diagnostic uncertainty in patients, parents, and physicians: a compensatory control theory perspective.

    McKoane A, Sherman DK

    Health psychology review 2023; (17(3)):439-455 doi:10.1080/17437199.2022.2086899.

    PMID: 35672909
  49. 49

    Clinical Reasoning: A 43-Year-Old Man With Subacute Onset of Vision Disturbances, Jaw Spasms, and Balance and Sleep Difficulties.

    Orozco E, Guo Y, Chen JJ, et al.

    Neurology 2022; (99(9)):387-392 doi:10.1212/WNL.0000000000200950.

    PMID: 35794020
  50. 50

    Treatment Options in Refractory Autoimmune Encephalitis.

    Dinoto A, Ferrari S, Mariotto S

    CNS drugs 2022; (36(9)):919-931 doi:10.1007/s40263-022-00943-z.

    PMID: 35917105
  51. 51

    Critical care management of meningitis and encephalitis: an update.

    Thy M, Gaudemer A, Vellieux G, Sonneville R

    Current opinion in critical care 2022; (28(5)):486-494 doi:10.1097/MCC.0000000000000980.

    PMID: 35975963
  52. 52

    Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies.

    Al-Chalabi M, DelCimmuto NR, Beran A, et al.

    Multiple sclerosis and related disorders 2022; (68()):104112 doi:10.1016/j.msard.2022.104112.

    PMID: 36029706
  53. 53

    Evaluation of multiple consensus criteria for autoimmune encephalitis and temporal analysis of symptoms in a pediatric encephalitis cohort.

    Pointon T, Ward R, Yeshokumar A, et al.

    Frontiers in neurology 2022; (13()):952317 doi:10.3389/fneur.2022.952317.

    PMID: 36237630
  54. 54

    Postdischarge Glucocorticoid Use and Clinical Outcomes of Multisystem Inflammatory Syndrome in Children.

    Son MBF, Berbert L, Young C, et al.

    JAMA network open 2022; (5(11)):e2241622 doi:10.1001/jamanetworkopen.2022.41622.

    PMID: 36367723
  55. 55

    Autoimmune Encephalitis Misdiagnosis in Adults.

    Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al.

    JAMA neurology 2023; (80(1)):30-39 doi:10.1001/jamaneurol.2022.4251.

    PMID: 36441519
  56. 56

    Transcription factors regulating the specification of brainstem respiratory neurons.

    Xia Y, Cui K, Alonso A, et al.

    Frontiers in molecular neuroscience 2022; (15()):1072475 doi:10.3389/fnmol.2022.1072475.

    PMID: 36523603
  57. 57

    Autoimmune Encephalitis Criteria in Clinical Practice.

    Orozco E, Valencia-Sanchez C, Britton J, et al.

    Neurology. Clinical practice 2023; (13(3)):e200151 doi:10.1212/CPJ.0000000000200151.

    PMID: 37124463
  58. 58

    Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease.

    Dalmau J, Graus F

    The Lancet. Neurology 2023; (22(6)):529-540 doi:10.1016/S1474-4422(23)00083-2.

    PMID: 37210100
  59. 59

    [Flexible endoscopic evaluation of swallowing in neurology].

    Lapa S

    Der Nervenarzt 2023; (94(8)):664-675 doi:10.1007/s00115-023-01517-0.

    PMID: 37378909
  60. 60

    Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria.

    Van Steenhoven RW, de Vries JM, Bruijstens AL, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(6)) doi:10.1212/NXI.0000000000200148.

    PMID: 37582614
  61. 61

    The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes.

    Bertram D, Tsaktanis T, Berthele A, Korn T

    Scientific reports 2023; (13(1)):17224 doi:10.1038/s41598-023-44427-6.

    PMID: 37821561
  62. 62

    Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis.

    Yang JH, Liu EN, Nguyen L, et al.

    Neurology 2023; (101(22)):e2300-e2313 doi:10.1212/WNL.0000000000207746.

    PMID: 37827848
  63. 63

    Antibody-Negative Autoimmune Encephalitis: A Single-Center Retrospective Analysis.

    Mojžišová H, Krýsl D, Hanzalová J, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2023; (10(6)) doi:10.1212/NXI.0000000000200170.

    PMID: 37879962
  64. 64

    Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.

    Hahn C, Budhram A, Alikhani K, et al.

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2024; 1-21 doi:10.1017/cjn.2024.16.

    PMID: 38312020
  65. 65

    Autoimmune and inflammatory neurological disorders in the intensive care unit.

    Legouy C, Cervantes A, Sonneville R, Thakur KT

    Current opinion in critical care 2024; (30(2)):142-150 doi:10.1097/MCC.0000000000001139.

    PMID: 38441114
  66. 66

    Clinical features and outcomes in children with seronegative autoimmune encephalitis.

    Madani J, Yea C, Mahjoub A, et al.

    Developmental medicine and child neurology 2024; (66(10)):1310-1318 doi:10.1111/dmcn.15896.

    PMID: 38491729
  67. 67

    Study on clinical features and factors related to long-term outcomes of antibody-negative autoimmune encephalitis.

    Han B, Dai Y, Peng J, et al.

    Annals of clinical and translational neurology 2024; (11(5)):1325-1337 doi:10.1002/acn3.52049.

    PMID: 38644648
  68. 68

    Swallowing Characteristics and Water Swallow Capacity in Patients with Parkinsonism.

    Martell P, Skogar Ö, Bergström L

    Dysphagia 2024; (39(6)):1078-1089 doi:10.1007/s00455-024-10685-3.

    PMID: 38703231
  69. 69

    Autoimmune Encephalitis.

    Irani SR

    Continuum (Minneapolis, Minn.) 2024; (30(4)):995-1020 doi:10.1212/CON.0000000000001448.

    PMID: 39088286
  70. 70

    Brazilian consensus recommendations on the diagnosis and treatment of autoimmune encephalitis in the adult and pediatric populations.

    Dutra LA, Silva PVC, Ferreira JHF, et al.

    Arquivos de neuro-psiquiatria 2024; (82(7)):1-15 doi:10.1055/s-0044-1788586.

    PMID: 39089672
  71. 71

    Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study.

    Mangioris G, Orozco E, Dubey D, et al.

    Journal of neurology 2024; (271(12)):7502-7515 doi:10.1007/s00415-024-12680-y.

    PMID: 39278895
  72. 72

    Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study.

    Cai L, Li G, Abdulaziz AT, et al.

    Epilepsia 2024; (65(11)):3199-3215 doi:10.1111/epi.18107.

    PMID: 39324872
  73. 73

    Rhombencephalitis With Long Segment Transverse Myelitis: A Presentation With a Rare Etiology.

    Dubey P, Seth S, Rao P, Naphade P

    Cureus 2024; (16(9)):e69386 doi:10.7759/cureus.69386.

    PMID: 39411647
  74. 74

    Patient-Reported Outcome Measures in NMDA Receptor Encephalitis.

    Heine J, Boeken OJ, Rekers S, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2025; (12(1)):e200343 doi:10.1212/NXI.0000000000200343.

    PMID: 39671210
  75. 75

    Autoimmune brainstem encephalitis: Clinical associations, outcomes, and proposed diagnostic criteria.

    Gilligan M, Thakolwiboon S, Orozco E, et al.

    Annals of clinical and translational neurology 2025; (12(1)):213-225 doi:10.1002/acn3.52273.

    PMID: 39708293
  76. 76

    Clinical features and factors associated with outcomes of antibody-negative autoimmune encephalitis in patients requiring intensive care.

    Li Z, He X, Li D, et al.

    Critical care (London, England) 2025; (29(1)):24 doi:10.1186/s13054-024-05233-2.

    PMID: 39815346
  77. 77

    Type 2 Respiratory Failure as an Initial Manifestation of Lambert-Eaton Myasthenic Syndrome Complicated by Paraneoplastic Autoimmune Encephalitis.

    Uemura S, Fujiwara S, Sasada T, et al.

    Cureus 2025; (17(1)):e78284 doi:10.7759/cureus.78284.

    PMID: 40026930
  78. 78

    How the clinical encounter shapes diagnostic uncertainty in pediatric chronic pain.

    Neville A, Clemente I, Meldrum ML, et al.

    The journal of pain 2025; (32()):105406 doi:10.1016/j.jpain.2025.105406.

    PMID: 40287028
  79. 79

    Does the Use of Intravenous Immunoglobulin Improve Clinical Outcomes in Adults With Autoimmune Encephalitis? A Systematic Review.

    Kalra A, Mackay O, Thomas-Jones E, et al.

    Brain and behavior 2025; (15(5)):e70491 doi:10.1002/brb3.70491.

    PMID: 40356296
  80. 80

    Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.

    Mukherjee A, Roy D, Chakravarty A

    Current neurology and neuroscience reports 2025; (25(1)):45 doi:10.1007/s11910-025-01432-8.

    PMID: 40591029
  81. 81

    Listeria rhombencephalitis in the postpartum period.

    Schneider J, Kim JY, Oey M

    BMJ case reports 2025; (18(7)) doi:10.1136/bcr-2025-266790.

    PMID: 40659385
  82. 82

    Clinical features and outcomes of paediatric probable antibody-negative autoimmune encephalitis.

    Kim HJ, Cha JH, Kim W, et al.

    Developmental medicine and child neurology 2026; (68(4)):549-557 doi:10.1111/dmcn.16456.

    PMID: 40751942
  83. 83

    Rhombencephalitis associated with varicella-zoster virus masquerading as Guillain-Barré syndrome.

    Al Shaaibi K, Phoophiboon V, Burns KEA

    BMC neurology 2025; (25(1)):324 doi:10.1186/s12883-025-04245-x.

    PMID: 40764927
  84. 84

    Harmful words: A qualitative survey of pain clinicians' perspectives on unhelpful messages in chronic pain.

    Jordan A, Brook-Rowland P, Noel M, Gauntlett-Gilbert J

    The journal of pain 2025; (35()):105524 doi:10.1016/j.jpain.2025.105524.

    PMID: 40783171
  85. 85

    The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium.

    Kazzi C, Seery N, Griffith S, et al.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2025; (34(12)):3635-3648 doi:10.1007/s11136-025-04052-4.

    PMID: 40886242
  86. 86

    Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium.

    Ko KY, Kazzi C, Seery N, et al.

    Journal of neurology 2025; (272(10)):665 doi:10.1007/s00415-025-13353-0.

    PMID: 41021036
  87. 87

    Subjective neuropsychological deficits in autoimmune encephalitis: Patient-informant discrepancies and cognitive test outcomes.

    Ko KY, Seery N, Kazzi C, et al.

    Journal of the neurological sciences 2025; (478()):123709 doi:10.1016/j.jns.2025.123709.

    PMID: 41075676
  88. 88

    Clinical efficacy and immunomodulation of double-filtration plasmapheresis in autoimmune encephalitis: A prospective study highlighting the importance of timely initiation.

    Li H, Wang K, Li Q, et al.

    Journal of translational autoimmunity 2025; (11()):100318 doi:10.1016/j.jtauto.2025.100318.

    PMID: 41079906
  89. 89

    Rituximab for antibody-negative combined central and peripheral demyelination presenting with acute respiratory failure: a case report and literature review.

    Zheng Y, Hou J, Jiang Y, et al.

    Frontiers in immunology 2025; (16()):1682211 doi:10.3389/fimmu.2025.1682211.

    PMID: 41181092
  90. 90

    Rituximab in the Intensive Care Unit: A Review of Indications and Clinical Considerations.

    Lincoln M, McGimsey T, O'Driscoll D

    Journal of intensive care medicine 2025; 8850666251409783 doi:10.1177/08850666251409783.

    PMID: 41451993
  91. 91

    Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis.

    Di Cosmo L, Mulic-Al Bunni S, Goh Y, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2026; (13(2)):e200540 doi:10.1212/NXI.0000000000200540.

    PMID: 41499723
  92. 92

    Immunotherapies on autoimmune encephalitis.

    Lemmens CMC, Van Sonderen A, Titulaer MJ

    Handbook of clinical neurology 2026; (214()):269-289 doi:10.1016/B978-0-323-90887-0.00004-3.

    PMID: 41526139
  93. 93

    Challenges in managing prolonged intensive care unit stay for Guillain-Barré syndrome-acute motor axonal neuropathy variant.

    Almakki S, Almubarak A, Alnaji Z, et al.

    SAGE open medical case reports 2026; (14()):2050313X261418766 doi:10.1177/2050313X261418766.

    PMID: 41625137
  94. 94

    Minimally Clinically Important Difference of the Clinical Assessment Scale in Autoimmune Encephalitis.

    Goh Y, Shin YH, Ahn SH, et al.

    Annals of clinical and translational neurology 2026; (13(6)):1283-1288 doi:10.1002/acn3.70360.

    PMID: 41784996
  95. 95

    Assessing healthcare experiences and barriers to care among individuals with ectodermal dysplasia.

    Swanson AK, Hammersmith KJ, Peng J, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41787517
  96. 96

    Neuropsychiatric Presentation of Non-paraneoplastic Voltage-Gated Calcium Channel Autoimmune Encephalitis: A Case Report.

    Philip S, Kaur S, Sahonta R, Pandian JD

    Cureus 2026; (18(2)):e102960 doi:10.7759/cureus.102960.

    PMID: 41798584
  97. 97

    Combination Versus Monotherapy in Acute Anti-LGI1 Encephalitis: A Real-World Dose Optimization Analysis.

    Tan Y, Sun M, Liu Q, et al.

    Neuropsychopharmacology reports 2026; (46(2)):e70112 doi:10.1002/npr2.70112.

    PMID: 41858102
  98. 98

    Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapy.

    Schwab H, Kegele J, Kowarik MC, et al.

    Frontiers in immunology 2026; (17()):1771609 doi:10.3389/fimmu.2026.1771609.

    PMID: 41884821
  99. 99

    후뇌염의 영상 소견 스펙트럼: 임상 화보.

    Arulnathan E, Sree S, Venugopal M, et al.

    Journal of the Korean Society of Radiology 2026; (87(2)):292-424 doi:10.3348/jksr.2024.0129.

    PMID: 41971108
  100. 100

    Current and Future Biomarkers in the Diagnosis of Autoimmune Encephalitis: A Review of Biomarker Detection Techniques and Their Performance.

    Plačenytė P, Giedraitienė N, Vaišvilas M

    Medicina (Kaunas, Lithuania) 2026; (62(5)) doi:10.3390/medicina62050896.

    PMID: 42195149
  101. 101

    Long-Term Outcomes in Antibody-Negative Autoimmune Encephalitis: A Systematic Review and Meta-Analysis.

    Mohapatra P, Chandu M, Kumar P, et al.

    Neurology. Clinical practice 2026; (16(2)):e200602 doi:10.1212/CPJ.0000000000200602.

    PMID: 42302198
  102. 102

    Case Report: A case of paraneoplastic autoimmune encephalitis with concurrent anti-GABABR and anti-SOX1 antibody positivity.

    Liu F, Jiang YH, Hu YF, et al.

    Frontiers in cellular neuroscience 2026; (20()):1816167 doi:10.3389/fncel.2026.1816167.

    PMID: 42494433
  103. 103

    Case Report: Anti-GQ1b antibody-positive overlap syndrome: a pediatric case involving the brainstem, spinal cord, and peripheral nerves.

    Zhang SJ, Zhu W, Ying QL, et al.

    Frontiers in immunology 2026; (17()):1821721 doi:10.3389/fimmu.2026.1821721.

    PMID: 42625776
  104. 104

    Relapse predictors and brain atrophy in antibody-positive and antibody-negative autoimmune encephalitis: a multicenter cohort study.

    Tang XH, Wang JX, Li H, et al.

    Frontiers in immunology 2026; (17()):1879021 doi:10.3389/fimmu.2026.1879021.

    PMID: 42712550